NovoCure (NVCR) Capital Expenditures (QoQ) (2015 - 2026)
NovoCure (NVCR) Capital Expenditures (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | NovoCure | 2.03 Bn | 1.59 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.24% |
| Mar 31, 2026 | 5.23% |
| Dec 31, 2025 | -13.42% |
| Sep 30, 2025 | 3.08% |
| Jun 30, 2025 | -48.30% |
| Mar 31, 2025 | 18.66% |
| Dec 31, 2024 | -16.30% |
| Sep 30, 2024 | -6.67% |
| Jun 30, 2024 | -2.87% |
| Mar 31, 2024 | 72.76% |
| Dec 31, 2023 | -5.96% |
| Sep 30, 2023 | 4.65% |
| Jun 30, 2023 | 13.85% |
| Mar 31, 2023 | -5.33% |
| Dec 31, 2022 | 12.77% |
| Sep 30, 2022 | 38.05% |
| Jun 30, 2022 | -18.89% |
| Mar 31, 2022 | -64.32% |
| Dec 31, 2021 | 332.94% |
| Sep 30, 2021 | 25.94% |